Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among women's health initiative postmenopausal women

Kei Hang K. Chan, Tianhua Niu, Yunsheng Ma, Nai Chieh Y. You, Yiqing Song, Eric M. Sobel, Yi Hsiang Hsu, Raji Balasubramanian, Yongxia Qiao, Lesley Tinker, Simin Liu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Context: Peroxisome proliferator-activated receptor-γ (PPARG) plays a pivotal role in adipogenesis and glucose homeostasis. Objective: We investigated whether PPARG gene variants were associated with type 2 diabetes (T2D) risk in the multiethnic Women's Health Initiative (WHI). Research Design and Methods: We assessed PPARG single-nucleotide polymorphisms (SNPs) in a case-control study nested in the prospective WHI observational study (WHI-OS) (1543 T2D cases and 2170 matched controls). After identifying 24 tagSNPs, we used multivariable logistic regression models and haplotype-based analyses to estimate these tagSNP-T2D associations. Single-SNP analyses were also conducted in another study of 5642 African American and Hispanic American women in the WHI SNP Health Association Resource (WHI-SHARe). Results: We found a borderline significant association between the Pro12Ala (rs1801282) variant and T2D risk in WHI-OS [odds ratio (OR) 0.51, 95% confidence interval (CI) 0.31-0.83, P = .01, combined group, additive model; P = .04, Hispanic American] and WHI-SHARe (OR 0.25, 95% CI 0.08-0.77, P = .02, Hispanic American) participants. In promoter region, rs6809631, rs9817428, rs10510411, rs12629293, and rs12636454 were also associated with T2D risk (range ORs0.68-0.78, 95% CIs 0.52-0.91 to 0.60-1.00, P≤.05)in WHI-OS, in which rs9817428 was replicated in then WHI-SHARe Hispanic American group (P = .04). Conclusions: The association between PPARG Pro12Ala SNP and increased T2D susceptibility was confirmed, with Pro12 as risk allele. Additional significant loci included 5 PPARG promoter variants.

Original languageEnglish (US)
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number3
DOIs
StatePublished - Mar 1 2013
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Women's Health
Medical problems
Type 2 Diabetes Mellitus
Polymorphism
Hispanic Americans
Single Nucleotide Polymorphism
Nucleotides
Logistic Models
Odds Ratio
Confidence Intervals
Adipogenesis
Health Resources
Genetic Promoter Regions
African Americans
Haplotypes
Observational Studies
Logistics
Case-Control Studies
Homeostasis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among women's health initiative postmenopausal women. / Chan, Kei Hang K.; Niu, Tianhua; Ma, Yunsheng; You, Nai Chieh Y.; Song, Yiqing; Sobel, Eric M.; Hsu, Yi Hsiang; Balasubramanian, Raji; Qiao, Yongxia; Tinker, Lesley; Liu, Simin.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 98, No. 3, 01.03.2013.

Research output: Contribution to journalArticle

Chan, Kei Hang K. ; Niu, Tianhua ; Ma, Yunsheng ; You, Nai Chieh Y. ; Song, Yiqing ; Sobel, Eric M. ; Hsu, Yi Hsiang ; Balasubramanian, Raji ; Qiao, Yongxia ; Tinker, Lesley ; Liu, Simin. / Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among women's health initiative postmenopausal women. In: Journal of Clinical Endocrinology and Metabolism. 2013 ; Vol. 98, No. 3.
@article{21ed7448d6ad4485a997348684f17cff,
title = "Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among women's health initiative postmenopausal women",
abstract = "Context: Peroxisome proliferator-activated receptor-γ (PPARG) plays a pivotal role in adipogenesis and glucose homeostasis. Objective: We investigated whether PPARG gene variants were associated with type 2 diabetes (T2D) risk in the multiethnic Women's Health Initiative (WHI). Research Design and Methods: We assessed PPARG single-nucleotide polymorphisms (SNPs) in a case-control study nested in the prospective WHI observational study (WHI-OS) (1543 T2D cases and 2170 matched controls). After identifying 24 tagSNPs, we used multivariable logistic regression models and haplotype-based analyses to estimate these tagSNP-T2D associations. Single-SNP analyses were also conducted in another study of 5642 African American and Hispanic American women in the WHI SNP Health Association Resource (WHI-SHARe). Results: We found a borderline significant association between the Pro12Ala (rs1801282) variant and T2D risk in WHI-OS [odds ratio (OR) 0.51, 95{\%} confidence interval (CI) 0.31-0.83, P = .01, combined group, additive model; P = .04, Hispanic American] and WHI-SHARe (OR 0.25, 95{\%} CI 0.08-0.77, P = .02, Hispanic American) participants. In promoter region, rs6809631, rs9817428, rs10510411, rs12629293, and rs12636454 were also associated with T2D risk (range ORs0.68-0.78, 95{\%} CIs 0.52-0.91 to 0.60-1.00, P≤.05)in WHI-OS, in which rs9817428 was replicated in then WHI-SHARe Hispanic American group (P = .04). Conclusions: The association between PPARG Pro12Ala SNP and increased T2D susceptibility was confirmed, with Pro12 as risk allele. Additional significant loci included 5 PPARG promoter variants.",
author = "Chan, {Kei Hang K.} and Tianhua Niu and Yunsheng Ma and You, {Nai Chieh Y.} and Yiqing Song and Sobel, {Eric M.} and Hsu, {Yi Hsiang} and Raji Balasubramanian and Yongxia Qiao and Lesley Tinker and Simin Liu",
year = "2013",
month = "3",
day = "1",
doi = "10.1210/jc.2012-3644",
language = "English (US)",
volume = "98",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among women's health initiative postmenopausal women

AU - Chan, Kei Hang K.

AU - Niu, Tianhua

AU - Ma, Yunsheng

AU - You, Nai Chieh Y.

AU - Song, Yiqing

AU - Sobel, Eric M.

AU - Hsu, Yi Hsiang

AU - Balasubramanian, Raji

AU - Qiao, Yongxia

AU - Tinker, Lesley

AU - Liu, Simin

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Context: Peroxisome proliferator-activated receptor-γ (PPARG) plays a pivotal role in adipogenesis and glucose homeostasis. Objective: We investigated whether PPARG gene variants were associated with type 2 diabetes (T2D) risk in the multiethnic Women's Health Initiative (WHI). Research Design and Methods: We assessed PPARG single-nucleotide polymorphisms (SNPs) in a case-control study nested in the prospective WHI observational study (WHI-OS) (1543 T2D cases and 2170 matched controls). After identifying 24 tagSNPs, we used multivariable logistic regression models and haplotype-based analyses to estimate these tagSNP-T2D associations. Single-SNP analyses were also conducted in another study of 5642 African American and Hispanic American women in the WHI SNP Health Association Resource (WHI-SHARe). Results: We found a borderline significant association between the Pro12Ala (rs1801282) variant and T2D risk in WHI-OS [odds ratio (OR) 0.51, 95% confidence interval (CI) 0.31-0.83, P = .01, combined group, additive model; P = .04, Hispanic American] and WHI-SHARe (OR 0.25, 95% CI 0.08-0.77, P = .02, Hispanic American) participants. In promoter region, rs6809631, rs9817428, rs10510411, rs12629293, and rs12636454 were also associated with T2D risk (range ORs0.68-0.78, 95% CIs 0.52-0.91 to 0.60-1.00, P≤.05)in WHI-OS, in which rs9817428 was replicated in then WHI-SHARe Hispanic American group (P = .04). Conclusions: The association between PPARG Pro12Ala SNP and increased T2D susceptibility was confirmed, with Pro12 as risk allele. Additional significant loci included 5 PPARG promoter variants.

AB - Context: Peroxisome proliferator-activated receptor-γ (PPARG) plays a pivotal role in adipogenesis and glucose homeostasis. Objective: We investigated whether PPARG gene variants were associated with type 2 diabetes (T2D) risk in the multiethnic Women's Health Initiative (WHI). Research Design and Methods: We assessed PPARG single-nucleotide polymorphisms (SNPs) in a case-control study nested in the prospective WHI observational study (WHI-OS) (1543 T2D cases and 2170 matched controls). After identifying 24 tagSNPs, we used multivariable logistic regression models and haplotype-based analyses to estimate these tagSNP-T2D associations. Single-SNP analyses were also conducted in another study of 5642 African American and Hispanic American women in the WHI SNP Health Association Resource (WHI-SHARe). Results: We found a borderline significant association between the Pro12Ala (rs1801282) variant and T2D risk in WHI-OS [odds ratio (OR) 0.51, 95% confidence interval (CI) 0.31-0.83, P = .01, combined group, additive model; P = .04, Hispanic American] and WHI-SHARe (OR 0.25, 95% CI 0.08-0.77, P = .02, Hispanic American) participants. In promoter region, rs6809631, rs9817428, rs10510411, rs12629293, and rs12636454 were also associated with T2D risk (range ORs0.68-0.78, 95% CIs 0.52-0.91 to 0.60-1.00, P≤.05)in WHI-OS, in which rs9817428 was replicated in then WHI-SHARe Hispanic American group (P = .04). Conclusions: The association between PPARG Pro12Ala SNP and increased T2D susceptibility was confirmed, with Pro12 as risk allele. Additional significant loci included 5 PPARG promoter variants.

UR - http://www.scopus.com/inward/record.url?scp=84874910905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874910905&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-3644

DO - 10.1210/jc.2012-3644

M3 - Article

C2 - 23386649

AN - SCOPUS:84874910905

VL - 98

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 3

ER -